Atlas Trials

68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CT

Clinical trial NCT02481726 · COMPLETED

Trial details

NCT number
NCT02481726
Sponsor
Xijing Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Lung CancerLung Tuberculosis
Start date
2014-03-01
Primary completion
2014-10-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.